Iowa Governor Kim Reynolds signed Senate File 2480 into law on Tuesday at the Stead Family Children’s Hospital, establishing a new 5-cent tax on vapes and alternative nicotine products. This legislative milestone, heavily championed by pediatric cancer survivors and their families, guarantees up to $3 million in annual funding for life-saving pediatric cancer research and clinical trials.
Under the new law, tax revenues will flow into the state’s health care trust fund. From there, the Iowa Board of Regents will receive up to $3 million annually to support physician-scientist leadership and clinical therapy trials at the University of Iowa’s pediatric facility. Any revenue generated beyond the $3 million cap will remain in the trust fund to support Iowa Medicaid.
While the funding goal was widely supported, the bill faced pushback during the 2026 legislative session for tying cancer research funding directly to the continued use of nicotine products. Some lawmakers advocated instead for House File 2758, which proposed a flat state appropriation of $1 per Iowan to secure the research budget without relying on vape sales.
| Feature / Metric | Enacted Law (SF 2480) | Proposed Alternative (HF 2758) |
|---|---|---|
| Funding Source | 5-cent tax on vapes and nicotine pouches | Standing state budget appropriation ($1 per Iowan) |
| Annual Research Allocation | Up to $3 million (surplus goes to Medicaid) | Flat $3 million |
| Tax Rate | $0.05 per mL of liquid / $0.05 per 20-pouch container | No new tax imposed |
Public health advocates also raised concerns that a 5-cent per-unit tax is too low to effectively deter youth vaping. Additionally, revenue projections remain highly contested. State analysts estimate the tax will not reach the $3 million mark until 2031, whereas industry representatives project first-year revenues could reach between $15 million and $18 million.
Meanwhile, local vape retailers expressed frustration, warning that the tax will force them to pass higher costs onto consumers. This comes on the heels of House File 2677, a restrictive 2024 law that limited permissible product sales and is currently facing federal court challenges. Shop owners argue the cumulative regulatory burden threatens the survival of small businesses.
Despite the economic and political debates, families of pediatric cancer patients emphasized the profound human impact of the bill. Advocates like Scott Kaas, whose daughter survived infant cancer, expressed deep gratitude to the legislators and the governor, noting that securing state-level funding is a vital victory in the ongoing fight against childhood cancer.
